New Delhi: Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh today launched the world's first COVID-19 intranasal vaccine, iNCOVACC.
The vaccine has been developed by India's Bharat Biotech. It will be available to the government for ₹ 325 per dose, but it will cost ₹ 800 to private hospitals.
The company, got the approval for the primary 2-dose schedule, and as a heterologous booster dose in December 2022. Before that, the Central Drugs Standard Control Organisation (CDSCO) had approved the restricted use of the intranasal vaccine in emergency situations in the age group of 18 and above.
Two doses of the vaccine are to be given 28 days apart.
